Emergent BioSolutions Inc. (EBS) NYSE
8.10
-0.23(-2.76%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
8.10
-0.23(-2.76%)
Currency In USD
| Market Cap | 661.26M |
| Enterprise Value | 1.03B |
| P/E Ratio | 8.24 |
| PEG Ratio | -0.27 |
| Price/Sales Ratio | 0.57 |
| Price/Book Ratio | 0.83 |
| Enterprise/Revenue | 1.07 |
| Enterprise/EBITDA | 3.93 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.07 |
| Operating Margin | 0.15 |
| Return On Assets | 0.04 |
| Return On Equity | 0.1 |
| Revenue | 742.9M |
| Revenue/Share | 13.89 |
| Gross Profit | 350.6M |
| EBITDA | 208.5M |
| Net Income | 52.6M |
| Diluted EPS | 0.93 |
| Total Cash | 205.4M |
| Total Cash/Share | 3.84 |
| Total Debt | 572.1M |
| Total Debt/Equity | 1.09 |
| Current Ratio | 5.01 |
| Book Value Per Share | 9.77 |
| 52-Week Change | 39.9 |
| 52-Week High | 14.06 |
| 52-Week Low | 4.02 |
| Moving Average 50 Days | 10.86 |
| Moving Average 200 Days | 9.34 |
| Average Volume | 1.02M |
| Shares Outstanding | 52.52M |
| % Held by Institutions | 81.6 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |